FDA Talk Papers Archives

2005 | 2004 | 2003 | 2002 | 2001 | 2000
1999 | 1998 | 1997 | 1996 | 1995 | Pre-1995

1999

December 1999

• FDA Cites Medical Device Reprocessor for Violations (Dec. 27)
• FDA Approves Celebrex for New Indication (Dec. 23)
• FDA Approves New Indication for Taxotere (Dec. 23)
• ColorMax Lenses (Dec. 21)
• First Topical Treatment for Nail Fungus Approved (Dec. 17)
• FDA Takes Action Against Firm Marketing Unapproved Drugs (Dec. 10)
• FDA Approves Zoloft for Post-traumatic Stress Disorder (Dec. 7)
• FDA Approves New Epilepsy Drug (Dec. 1)

November 1999

• FDA Approves New Drug to Reduce Risk of Stroke (Nov. 23)
• FDA Warns Against Consuming Triax Metabolic Accelerator (Nov. 11)
• FDA Proposes New Strategy on Reuse of Single-Use Medical Devices (Nov. 1)

October 1999

• FDA Approves Tamiflu for Influenza (Oct. 27)
• FDA Approves Laser for Lasik (Oct. 21)
• FDA Approves New Health Claim for Soy Protein and Coronary Heart Disease (Oct. 20)
• FDA Announces Food Safety Grants (Oct. 18)

September 1999

• FDA Approves Two New Devices for Aneurysm Repair (Sept. 28)
• FDA Approves the First New Ophthalmic Mast Cell Stabilizer for Prevention of Itchy Eyes Due to Allergic Conjunctivitis (Sept. 24)
• Approval of Synercid for Certain Vancomycin Resistant Infections (Sept. 21)
• FDA Approves New Chemotherapy Agent to Treat Breast Cancer (Sept. 16)
• FDA Approves Rapamune to Prevent Organ Rejection (Sept. 15)

August 1999

• FDA Clears Quick New Lab Test for Pneumonia Antigen (Aug. 30)
• The Year 2000 Date Problem and Medical Devices (Aug. 24)
• FDA Issues Final Rule on OTC Drug Products Containing Colloidal Silver (Aug. 17)
• New Precautionary Measures to Reduce the Theoretical Risk of New Variant CJD from Blood Products (Aug. 17)
• FDA Approves New Drug for Brain Cancer (Aug. 11)
• FDA Issues Final Guidance for Direct-to-Consumer Rx Drug Advertisements (Aug. 6)
• New FDA Ads: Selling Tobacco to Kids Is Illegal for a Reason (Aug. 2)

July 1999

• FDA Approves Relenza (Zanamivir for Inhalation) for Influenza Treatment (July 27)
• Serious Manufacturing Deficiencies with Abbokinase Prompt FDA Letter to Abbott Labs (July 16)
• FDA Approves Pioglitazone to Treat Type 2 Diabetes (July 16)
• FDA Approves First Topical Treatment for Heartworm Prevention for Dogs and Cats (July 12)

June 1999

• All Milk and Milk-Containing Food Products from Belgium to Be Detained at Ports of Entry (June 23)
• Janssen Pharmaceutica Announces the Withdrawal of Hismanal from the Market (June 21)
• New Labeling and Use Changes for Rezulin (June 16)
• All Eggs and Egg-Containing Products from Belgium, France and the Netherlands and Animal Feed from European Countries to Be Detained at Ports of Entry (June 11)
• FDA Issues Public Health Advisory on Liver Toxicity Associated with the Antibiotic Trovan (June 9)

May 1999

• FDA Approves Rosiglitazone to Treat Type II Diabetes (May 26)
• FDA Approves Vioxx for Osteoarthritis, Pain and Menstrual Pain (May 21)
• Sunscreen Regulations Finalized (May 21)
• New Warning for Arthritis Drug, Enbrel (May 12)
• FDA Warns About GBL-Related Products (May 11)

April 1999

• FDA Approves First Home Test for Hepatitis C Virus (April 29)
• FDA Approves Orlistat for Obesity (April 26)
• FDA Approves New Breast Imaging Device (April 19)
• FDA Approves Amprenavir for HIV Infection (April 16)
• FDA Approves Eye Implant to Correct Mild Nearsightedness (April 9)
• First Biologic Approved for Clotting Disorder (April 1)

March 1999

• FDA Approves First Ulcer Drug for Horses (March 18)
• FDA Approves New Device to Remove Blood Clots from Coronary Arteries (March 15)
• FDA Stops Importation and Distribution of Contaminated Animal Drugs (March 11)

February 1999

• FDA Warns Consumers About Frozen Mamey (Feb. 20)

Spanish version
• FDA Clears New Test for Lyme Disease (Feb. 16)
• FDA Licenses Improved Supplemental Test for Hepatitis C (Feb. 12)
• FDA Approves Novel Treatment for Rare Form of Cancer (Feb. 5)
• 2000 Budget Proposal for FDA (Feb. 1)

January 1999

• Recall of One Lot of Tripedia Because of Subpotent Diphtheria Component (Jan. 29)
• FDA Warns About Products Containing Gamma Butyrolactone or GBL and Asks Companies to Issue a Recall (Jan. 21)
• FDA's Report on New Health Care Products Approved in 1998 (Jan. 15)
• FDA Approves New Treatment for Painful Leg Disorder (Jan. 15)
• FDA Approves First Behavioral Drugs for Dogs (Jan. 5)
• Expedited Review Given to Food Additive Petitions that Provide Food Safety Solutions (Jan. 5)

Top